Nasonex Nasal Spray
Company: Schering-PloughApproval Status: Approved January 1999
Treatment for: Immunology/Allergy
General Information
Nasonex has been approved for the prophylaxis and treatment of the nasal symptoms of seasonal allergic rhinitis and the treatment of the nasal symptoms of perennial allergic rhinitis, in adults and children 12 years of age and older.
Nasonex Nasal Spray Drug Information
The Nasonex Nasal Spray drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
